Warby Parker Inc. financial data

Symbol
WRBY on NYSE
Industry
Ophthalmic Goods
Location
233 Spring Street, 6 Th Floor East, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
JAND, Inc. (to 3/23/2018)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 245 % -1.24%
Quick Ratio 48.2 % -15.4%
Debt-to-equity 88.2 % -2.57%
Return On Equity -14.5 % +39.4%
Return On Assets -7.76 % +38.7%
Operating Margin -7.7 % +35.9%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 988M USD +5.52%
Common Stock, Value, Issued 12K USD 0%
Weighted Average Number of Shares Outstanding, Basic 120M shares +2.82%
Weighted Average Number of Shares Outstanding, Diluted 120M shares +2.82%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 720M USD +13.7%
Operating Income (Loss) -55.4M USD +27.1%
Nonoperating Income (Expense) 10.2M USD +90.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -45.2M USD +36%
Income Tax Expense (Benefit) 677K USD +357%
Net Income (Loss) Attributable to Parent -45.9M USD +35.2%
Earnings Per Share, Basic -0.39 USD/shares +36.1%
Earnings Per Share, Diluted -0.39 USD/shares +36.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 238M USD +11.9%
Accounts Receivable, after Allowance for Credit Loss, Current 1.21M USD +2.72%
Inventory, Net 53.3M USD -10.8%
Assets, Current 309M USD +7.15%
Property, Plant and Equipment, Net 163M USD +13.3%
Operating Lease, Right-of-Use Asset 138M USD +12.9%
Other Assets, Noncurrent 8.7M USD +12.9%
Assets 618M USD +10.1%
Accounts Payable, Current 24.7M USD +3.84%
Employee-related Liabilities, Current 9.55M USD +5.25%
Accrued Liabilities, Current 47.7M USD +11.6%
Contract with Customer, Liability, Current 21.1M USD +11.1%
Liabilities, Current 121M USD +9.6%
Operating Lease, Liability, Noncurrent 167M USD +12.8%
Other Liabilities, Noncurrent 1.1M USD -25.2%
Liabilities 289M USD +11.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.64M USD -20%
Retained Earnings (Accumulated Deficit) -676M USD -7.28%
Stockholders' Equity Attributable to Parent 329M USD +9.05%
Liabilities and Equity 618M USD +10.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 19.9M USD +131%
Net Cash Provided by (Used in) Financing Activities 91K USD +12.3%
Net Cash Provided by (Used in) Investing Activities -16.4M USD -32.7%
Common Stock, Shares Authorized 1.05B shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.49M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 238M USD +11.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 76K USD +52%
Deferred Tax Assets, Valuation Allowance 69.4M USD -2.04%
Deferred Tax Assets, Gross 122M USD -1.73%
Operating Lease, Liability 192M USD +12.9%
Payments to Acquire Property, Plant, and Equipment 14.4M USD +16.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -46.2M USD +35.9%
Lessee, Operating Lease, Liability, to be Paid 226M USD +9.43%
Property, Plant and Equipment, Gross 299M USD +22.2%
Operating Lease, Liability, Current 25.6M USD +13.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 42.2M USD +21.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 38M USD +3.24%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +21.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 34M USD -6.57%
Lessee, Operating Lease, Liability, to be Paid, Year Three 39.6M USD +19.2%
Deferred Tax Assets, Operating Loss Carryforwards 49.2M USD -10.9%
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 34.2M USD +14.3%
Additional Paid in Capital 1.01B USD +7.87%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 10.6M USD +15.8%
Deferred Tax Assets, Net of Valuation Allowance 53.1M USD -1.31%
Share-based Payment Arrangement, Expense 60.6M USD -26%